A case of Mycobacterium goodiiprosthetic valve endocarditis in a non-immunocompromised patient: use of 16S rDNA analysis for rapid diagnosis
© Jönsson et al.; licensee BioMed Central Ltd. 2012
Received: 8 December 2011
Accepted: 29 October 2012
Published: 14 November 2012
Mycobacterium goodii is a rare cause of significant infection. M. goodii has mainly been associated with lymphadenitis, cellulitis, osteomyelitis, and wound infection.
A case of a 76-year-old Caucasian female is presented. The patient developed a prosthetic valve endocarditis caused by M. goodii. She had also suffered from severe neurological symptoms related to a septic emboli that could be demonstrated as an ischemic lesion found on CT of the brain. Transesophageal echocardiography verified a large vegetation attached to the prosthetic valve. Commonly used blood culture bottles showed growth of the bacteria after 3 days.
Although M. goodii is rarely involved in these kinds of severe infections, rapidly growing mycobacteria should be recognized during conventional bacterial investigations and identified by molecular tools such as analysis of 16S rDNA. Species identification of nontuberculous mycobacteria is demanding and is preferably done in collaboration with a mycobacterial laboratory. An early diagnosis provides the opportunity for adequate treatment. In the present case, prolonged antimicrobial treatment and surgery with replacement of the prosthetic valve was successful.
KeywordsMycobacterium goodii NTM Endocarditis Septic emboli Prosthetic valve 16S rDNA analysis
Mycobacterium goodii was identified in 1999 as a rapidly growing non tuberculous mycobacteria (NTM) species related to the Mycobacterium smegmatis group isolated from human wound infections . M. goodii has previously been associated with sporadic cases of cellulitis, osteomyelitis, infected pacemaker sites, lipoid pneumonia [1, 2], and bursitis . M. goodii has also been related to minor hospital outbreaks in patients receiving surgical implants . However, there has been no reported case of native or prosthetic valve endocarditis due to M. goodii. Since 1978, there are at least 9 cases reported in the literature with native and prosthetic valve endocarditis recognized to belong to the M. fortuitum group . Some of these patients were probably more susceptible to this type of infection due to underlying medical conditions such as HIV, intravenous drug use and renal failure . Here we present a case of prosthetic valve endocarditis caused by M. goodii.
A 76-year-old Caucasian female was admitted to our hospital in September 2009 with a sudden onset of dyspnea that had emerged during dancing a foxtrot. She was previously remarkably healthy and lived a very active life with hobbies like dancing and gardening. On initial assessment at the Emergency Department, she had no history of chills, fever, night sweats, cough or chest pain. Physical examination revealed a severe respiratory distress requiring oxygen treatment. Ultrasound examination of the heart was consistent with a mitral valve insufficiency caused by a rupture of chordae tendineae. Coronary angiography was normal except for a significant proximal stenosis found in D2. Eleven days after admission (September 28) the patient received a biological mitral valve replacement (Edward Magna Nr 25, Edwards Lifesciences Corp, Irvine, CA, USA) and a coronary artery bypass of D2 was also performed. The postoperative course was uneventful, and the patient was discharged from the hospital in good health on the 5th of October.
On the 15th of January 2010, the patient was readmitted to the Department of Neurology. The patient had suffered from general fatigue for at least 2–3 weeks, and had experienced slurred speech, poor balance, and disorientation to time and places for at least 24 hours. Initial neurological examination showed difficulty in walking due to poor balance. She was afebrile. Computed tomography (CT) of the brain revealed an ischemic lesion of the right cerebellar hemisphere, and she was assumed to have suffered from episodes of transient ischemic attacks and stroke. No blood cultures were drawn, and the patient was discharged. Further investigation as an out-patient revealed normal results from carotid Doppler, electroencephalography, and Holter ambulatory electrocardiography.
The patient was readmitted to the Emergency Department on the 2nd of February 2010. She was again confused with slurred speech, complained about general weakness, and had now a temperature of 40.2°C. Her heart rate was 99 beats per minute without cardiac murmurs, the blood pressure was 100/45 mmHg, and further physical examination was normal. Laboratory investigations showed the following results: hemoglobin 101 g/L, leukocyte count 7.1 × 109/L (ref. 4–10 × 109/L), platelet count 155 × 109/L (ref. 140–400 × 109/L), and C-reactive protein (CRP) was 110 mg/L (ref. <3.0 mg/L). Serum sodium, potassium and creatinine were within normal ranges. After securing four sets of blood cultures, the patient was initially given empirical treatment for bacterial meningitis with intravenous ampicillin, cefotaxime, and betamethasone. However, she developed no stiffness of the neck and further analysis of cerebrospinal fluid showed no signs of meningitis. Also, chest radiography was normal, and CT of the brain did not reveal any new lesions including abscesses. Transesophageal echocardiography (TEE) was inconclusive with an unclear structure found floating in the left auricle. No vegetation or insufficiency was described. The patient rapidly improved, became afebrile and was discharged after two days of hospitalization. She was prescribed oral amoxicillin 500 mg t.i.d. for 7 days.
The antibiotic resistance pattern of the Mycobacterium goodii isolated from blood cultures
The patient went through mitral valve replacement surgery on the 19th of February, again with a similar biological prosthetic valve (Edward Magna Nr 25, Edwards Lifesciences Corp, Irvine, CA, USA). The rationales for this decision were the finding of a prosthetic valve endocarditis due to a highly resistant microorganism and a large vegetation with a risk of new episodes of embolization. At surgery a vegetation was found and there were signs of infection surrounding the prosthetic valve ring. Cultures from the vegetation showed no growth, but 16S rDNA gene sequencing was consistent with the findings of M. goodii. After surgery there was a dramatic improvement of the patient’s general condition. Meropenem was replaced by ampicillin due to lower MIC-value (Table 1), but during the third week of treatment CRP was repeatedly found to be about 70 mg/L (Figure 1). The antibiotic treatment was changed in accord with the susceptibility pattern that favoured the combination of tigecycline and ciprofloxacin (Table 1). The following two weeks CRP dropped to 6.1 mg/L. The patient was discharged on March 23 in good health and continued with the combination of oral doxycycline and ciprofloxacin for an additional eleven weeks. She was followed clinically and with laboratory analyses for 30 weeks. CRP remained at a normal level and repeatedly drawn blood cultures showed no bacterial growth (Figure 1).
Infective endocarditis caused by M. goodii has to our knowledge not previously been described. M. goodii is a rapidly growing NTM, and visible colonies are formed on Loewenstein-Jensen culture medium within 7 days of incubation . Microbiological diagnosis is obtained by microscopy for acid-fast bacilli on secretions or biopsy, and by culture. Species identification of NTM is demanding and often a combination of biochemical and/or molecular methods needs to be applied. In many cases 16S rDNA-sequencing is enough for species identification but a number of NTMs have similar gene sequences enhancing the importance of several different approaches to identify NTMs at a species level .
NTMs are found in the natural environment throughout the world and include more than 135 different species. Rapidly growing NTMs have been isolated from potable and natural water, and in soil. They can also be isolated from contaminated tap water. There are evidence suggesting that nosocomial transmission have occurred for M. fortuitum, M. chelonae, M. abscessus, and M. goodii[4, 9], which resulted in conditions ranging from harmless colonization to invasive infection. One explanation to this problem might be that many of the nontuberculous mycobacteria are resistant to disinfectants , and an effective disinfectant or antiseptic against M. goodii has not been reported.
NTM infections in surgical patients have been reported in a wide variety of settings. The use of colonized aqueous solutions and inadequate sterilization or disinfection of surgical equipment are often factors involved in these infections. M. fortuitum and M. chelonae have caused multiple outbreaks of sternal wound infection and endocarditis after cardiac surgery. One outbreak was traced to contaminated tap water that had been used to make cardioplegia solution. The highest mortality rates have been reported in patients with prosthetic valve replacements [10–13]. The implantation of porcine heart valves colonized with M. chelonae during manufacture resulted in pericarditis and endocarditis [14, 15]. M. smegmatis, M. chelonae, M. gordonae, and M. fortuitum have caused isolated cases of prosthetic valve endocarditis in the immediate postoperative period. M. chelonae, M. fortuitum, and M. smegmatis have been retrieved in isolated cases of postoperative sternal wound infections and mediastinitis [13, 16, 17]. M. chelonae has been isolated from vein graft harvest site infections after cardiac bypass surgery .
Our patient had received a prosthetic mitral valve four months before the infection gave any obvious symptoms such as fever. It seems likely that our patient had a prolonged, indolent infection that was acquired during surgery, as indicated by reports of porcine aortic valves contaminated by other NTMs [14, 15]. During the observed period (January 2010 to October 2011), there was no other patient found with a M. goodii infection at our hospital, suggesting no obvious environmental source of contamination. However, no further investigation regarding an environmental source was performed, and thus it can not be determined whether the valve prosthesis was contaminated before or during surgery. In retrospect, our patient had never really regained her strength after the first operation and had suffered from general fatigue. Also, we believe that her neurological symptoms already on January 15th, including the ischemic lesion found on CT of the brain, represent embolic lesions from the prosthetic endocarditis. The very late onset of clear signs of infection in our patient is different from what has been previously described in patients with M. goodii associated surgical implant infections (3 days-4 weeks) .
Antimicrobial susceptibility data for M. goodii are sparse. Brown et al.  showed that all M. goodii isolates were susceptible to amikacin, doxycycline, ciprofloxacin, and sulfamethoxazole, and were variably susceptible to cefoxitin and clarithromycin. These bacteria are usually also susceptible to ethambutol and exhibit good in vitro susceptibility to gatifloxacin and ciprofloxacin . Commonly used antimicrobials include trimethoprim/sulfamethoxazole, doxycycline, and ciprofloxacin. Intravenous amikacin and imipenem have been used for severe cases . However, there are few data on the clinical validation of using susceptibility breakpoints of tested drugs. Notably, tigecycline has to our knowledge not been previously used in the treatment of M. goodii disease, and in the present case we believe that tigecycline treatment contributed to the successful outcome. In prosthetic endocarditis, surgical excision of the valve is probably necessary besides treatment with a combination of antibiotics for about 4 months . The in vitro susceptibility pattern observed for M. goodii in this investigation is consistent with previously reported findings. Notably, there are specific culturing techniques for the recovery of mycobacterial blood stream infections which are used when mycobacterial infection is highly suspected, but this case highlights that commonly used blood culture bottles such as bioMerieux, FAN-bottles may be sufficient to detect rapidly growing NTM.
In summary, M. goodii is a rapidly growing mycobacterium increasingly recognized as an important human pathogen. It is most commonly implicated in surgical site and posttraumatic infections, but is also associated with respiratory infections in patients with lipoid pneumonia. Identification of the organism is best accomplished by molecular techniques and 16S rDNA-sequencing is an example of a useful analysis in suspected NTM disease. Our patient history highlights the importance of rapidly performed testing for mycobacteria in prosthesis-related infections.
Written informed consent was obtained from the patient for publication of this case and any accompanying imaged. A copy of the written consent is available by Series Editor of this journal.
Polymerase chain reaction
Non tuberculous mycobacteria
- Brown BA, Springer B, Steingrube VA, Wilson RW, Pfyffer GE, Garcia MJ, Menendez MC, Rodriguez-Salgado B, Jost KC, Chiu SH, et al: Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol. 1999, 49 (Pt 4): 1493-1511.View ArticlePubMedGoogle Scholar
- Brown-Elliott BA, Wallace RJ: Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002, 15 (4): 716-746. 10.1128/CMR.15.4.716-746.2002.View ArticlePubMedPubMed CentralGoogle Scholar
- Friedman ND, Sexton DJ: Bursitis due to Mycobacterium goodii, a recently described, rapidly growing mycobacterium. J Clin Microbiol. 2001, 39 (1): 404-405. 10.1128/JCM.39.1.404-405.2001.View ArticlePubMedPubMed CentralGoogle Scholar
- Ferguson DD, Gershman K, Jensen B, Arduino MJ, Yakrus MA, Cooksey RC, Srinivasan A: Mycobacterium goodii infections associated with surgical implants at Colorado hospital. Emerg Infect Dis. 2004, 10 (10): 1868-1871.View ArticlePubMedPubMed CentralGoogle Scholar
- Spell DW, Szurgot JG, Greer RW, Brown JW: Native valve endocarditis due to Mycobacterium fortuitum biovar fortuitum: case report and review. Clin Infect Dis. 2000, 30 (3): 605-606. 10.1086/313695.View ArticlePubMedGoogle Scholar
- Kahn F, Linder A, Petersson AC, Christensson B, Rasmussen M: Axillary abscess complicated by venous thrombosis: identification of Streptococcus pyogenes by 16S PCR. J Clin Microbiol. 2010, 48 (9): 3435-3437. 10.1128/JCM.00373-10.View ArticlePubMedPubMed CentralGoogle Scholar
- Petrini B: Non-tuberculous mycobacterial infections. Scand J Infect Dis. 2006, 38 (4): 246-255. 10.1080/00365540500444652.View ArticlePubMedGoogle Scholar
- Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al: An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007, 175 (4): 367-416. 10.1164/rccm.200604-571ST.View ArticlePubMedGoogle Scholar
- Wallace RJ, Brown BA, Griffith DE: Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol. 1998, 52: 453-490. 10.1146/annurev.micro.52.1.453.View ArticlePubMedGoogle Scholar
- Szabo I, Sarkozi K: Mycobacterium chelonae endemy after heart surgery with fatal consequences. Am Rev Respir Dis. 1980, 121: 607-View ArticleGoogle Scholar
- Hoffman PC, Fraser DW, Robicsek F, O’Bar PR, Mauney CU: Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex. J Infect Dis. 1981, 143 (4): 533-542. 10.1093/infdis/143.4.533.View ArticlePubMedGoogle Scholar
- Kuritsky JN, Bullen MG, Broome CV, Silcox VA, Good RC, Wallace RJ: Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med. 1983, 98 (6): 938-939.View ArticlePubMedGoogle Scholar
- Robicsek F, Daugherty HK, Cook JW, Selle JG, Masters TN, O’Bar PR, Fernandez CR, Mauney CU, Calhoun DM: Mycobacterium fortuitum epidemics after open-heart surgery. J Thorac Cardiovasc Surg. 1978, 75 (1): 91-96.PubMedGoogle Scholar
- Laskowski LF, Marr JJ, Spernoga JF, Frank NJ, Barner HB, Kaiser G, Tyras DH: Fastidious mycobacteria grown from porcine prosthetic-heart-valve cultures. N Engl J Med. 1977, 297 (2): 101-102. 10.1056/NEJM197707142970209.View ArticlePubMedGoogle Scholar
- Levy C, Curtin JA, Watkins A, Marsh B, Garcia J, Mispireta L: Mycobacterium chelonei infection of porcine heart valves. N Engl J Med. 1977, 297 (12): 667-668.View ArticlePubMedGoogle Scholar
- Wallace RJ, Nash DR, Tsukamura M, Blacklock ZM, Silcox VA: Human disease due to Mycobacterium smegmatis. J Infect Dis. 1988, 158 (1): 52-59. 10.1093/infdis/158.1.52.View ArticlePubMedGoogle Scholar
- Syed AU, Hussain R, Bhat AN, al Rasheed M, al Qethami H, al Faraidi Y, al Fagih MR: Mediastinitis due to Mycobacterium fortuitum infection following Fontan operation in a child. Scand Cardiovasc J. 1997, 31 (5): 311-313. 10.3109/14017439709069553.View ArticlePubMedGoogle Scholar
- Engelhardt E, Feldmann R, Skaria A, Salomon D: Postoperative infection with Mycobacterium chelonae. Hautarzt. 1996, 47 (11): 863-866. 10.1007/s001050050523.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/12/301/prepub